Oxford Biomedica Logo Image

Oxford Biomedica

Oxford Biomedica Banner Image

Most Recent Annual Report

2017 Annual Report and Interactive Annual Report

Oxford Biomedica

Oxford Biomedica does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Oxford Biomedica

201-500 Employees
Based in Oxford, England

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy company focused on developing life-changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the “Group”) have built a sector leading lentiviral vector delivery platform (LentiVector®) through which the Group develops in vivo and ex-vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

Ticker:
OXB
Exchange:
LSE (See More LSE Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol